ViAqua Therapeutics

About:

ViAqua Therapeutics is developing the first orally administered treatment for aquaculture.

Top Investors: Technion - Israel Institute of Technology, S2G Ventures, Israel Innovation Authority, Clay Capital, Trendlines Group

Description:

ViAqua Therapeutics Ltd develops drugs and therapeutics for aquaculture. The company was founded in 2014 and is based in Israel.ViAqua Therapeutics is developing the first orally administered treatment for aquaculture.The Company’s management bring a broad range of business development, technology development, management, and industrial biotech experience.

Total Funding Amount:

$12.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Misgav, HaZafon, Israel

Founded Date:

2014-01-01

Contact Email:

shai.u(AT)viaqua-t.com

Founders:

Shai Einbinder, Shai Ufaz

Number of Employees:

11-50

Last Funding Date:

2023-09-05

IPO Status:

Private

Industries: